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At certain points during lifetime one needs to take a break
and anniversaries seem to be made for that. This is chance
for a thoughtful look back, to separate the grain from the
chaff, and maybe to reconcile with the spirits of the past;
all this to get the things done better in the future.
Already at its foundation, Sanatorium for tuberculosis
Golnik, nowadays University Clinic of Respiratory and
Allergic Diseases Golnik, was sized for whole country and
even beyond; the heritage still to follow in current days.
The visionary way was felt at that time as addressing
public health problems was in-house doctrine. This has
translated to a long history of acknowledging the importance
of not only up-to-date diagnostic and therapeutic service
but also of preventive approach. In ancient Greece, these
two approaches were epitomized by the daughters of
Aesculapius, Panacea and Hygieia, goddess of healing and of
health.1 It is therefore not a mere chance that Aesculapius’
attributes are embedded in Golnik’s sign (Fig. 1).
Fig. 1. University Clinic of Respiratory and Allergic Diseases Golnik’s
sign. It represents attributes of Aesculapius, a rod and a snake,
which is entwined in the shape of capital letter “G” (work of
Slovenian art historian Dr. Lojze Gostisa).
In line with time, tuberculosis was managed in a multidis-
ciplinary fashion including outpatient clinics, ﬂuorographic
campaigns, vaccination and health education.2 The mass
preventive ﬂuorographic screenings in population older than
15 years made Golnik the banner holder within Slovenia.
Although obsolete from today’s point of view, primarily due
to low effectiveness and high costs, it was cutting edge ap-
proach at its time and Golnik followed it promptly in steps of
public health practice and curative medicine. Already in the
early developments, the importance of reporting ﬁndings
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and sharing the knowledge beyond borders was recognized.3
Indeed, papers from Second World War era were quickly
acknowledged and taken up by the scientiﬁc community
of former Yugoslavia.4–6 Efforts eventually evolved to a
journal Plucˇne bolesti i tuberkuloza (Lung diseases and
tuberculosis), with Golnik as one of the founders and place
of last editorial ofﬁce. The concept of population screening
to detect initial disease forms, which would allow early and
effective treatment in the preclinical stage, has withstood
the scrutiny and survived until today, particularly in
chronic diseases. With increasing burden of chronic diseases
aggravated by ageing population, transition was needed
thus Golnik transformed to a regional centre of excellence
as a chest clinic and research institution. Currently, the
ﬂagships are in the ﬁelds of lung cancer,7 rare and orphan
lung diseases,8,9 allergy,10 and also chronic pulmonary and
cardiac disease.11–15 It however remains referral centre
for tuberculosis for a population of 2 million. Through
involvement in various scientiﬁc organisations, a network
of international contacts has been build and contribution to
clinical recommendations and guidelines is apparent.16,17
The primary focus, however, remains patient centred
good clinical practice. Today, chronic diseases are the
leading causes of mortality and disability worldwide and
will cause over three quarters of all deaths by 2030.18
The challenges are therefore shifting and health care
systems may be insufﬁciently prepared to cope with ﬁnancial
burden of chronic diseases. Chronic obstructive pulmonary
disease (COPD) certainly is one of key conditions to focus
on. In the University Clinic of Respiratory and Allergic
Diseases Golnik we are aware of this so comprehensive
measures are underway. Epidemiological data,19 insight into
patophysiology,20 and risk stratiﬁcation21–24 are cumulating
which sets the stage for interventional activities. Another
examples are rare clinical conditions which should be
managed in high experienced volume centers with adequate
diagnostic and therapeutic resources. As both frequently are
moving targets, ongoing research and testing of available
versus emerging knowledge is mandatory. In allergology,
for instance, testing of patients with a potentially life
threatening disease like drug or insect venom allergy should
either clearly conﬁrm or rule out the possibility of allergic
reaction when patient is exposed to allergen. In number of
diagnostic tests, including honeybee venom,25 antibiotic,26
and acetylsalicylic acid27 allergy, the jury is still out.
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In clinical practice we are too often seduced by
clinical trials testing pharmacological interventions and
may become distant from the patient. Patients however
may have other preferences thus health care providers
and researchers have to understand their needs and
think beyond mortality and morbidity towards symptom
improvement and health-related quality of life. In this
context, we particularly need to bring the patients (and
caregivers) back into the loop. Current clinical practice and
models that are in place in University Clinic of Respiratory
and Allergic Diseases Golnik are successfully implementing
known evidence from guidelines. Additionally, vibrant
clinical research activity in search of better diagnostic
and treatment possibilities is ongoing. Transcutaneous
electrical muscle stimulation is acknowledged method for
cardiopulmonary rehabilitation whereas its feasibility and
efﬁcacy during COPD exacerbation have not been adequately
validated. According to our recent ﬁndings, procedure is
feasible28 and patient-centered outcome study is initiating.
Many interventions have been implemented to reduce the
social, health and ﬁnancial impacts of chronic disease but
simple transfer from research setting into clinical practice
or other countries may be difﬁcult.29 With this in mind,
coordinated discharge at hospitalization for exacerbation
of COPD project that combines different in-hospital and
out-of-hospital proﬁles as well as patient (and caregivers)
input was initiated. In this randomized trial,30 coordinated
discharge and post-discharge activities, which should make
transfer from hospital to home environment and general
practitioner as smooth as possible, is being compared to
usual care. In view of inconclusive data for COPD, our
study should contribute to current body of evidence about
coordinated discharge effectiveness. It could also give
important guidance for resource management and daily
clinical practice.
The educational role of the Golnik is also one of
some signiﬁcance, encompassing both the education and
mentoring of health care professionals, as well as education
of patients for effective management of their disease.
Integration of health promotion and health education into
clinical setting follows the concept of International Network
of Health Promoting Hospitals and Health Services.31
Through its activities, Golnik has become a member of
the Network in early 2011. Currently, Golnik coordinates
efforts to set up a National Network with other collaborating
Slovenian health care institutions.
In a person we can discriminate between biological and
actual age. Same holds true for institutions. Maintaining
good ﬁtness, sharp intellectual exercise, and coping with the
challenges should keep the motor running for anniversaries
to come.
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